연구성과로 돌아가기

2023 연구성과별 연구자 정보 (835 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of Kumpe access catheter for pre-percutaneous nephrolithotomy renal access in modified supine percutaneous nephrolithotomy Kim, Bum Soo Kim, BS 13 교신저자 Kyungpook Natl Univ Hosp, Dept Urol, 130 Dongdeok Ro, Daegu 41944, South Korea ADR-9663-2022 Kim, Soo-Yeon kangjk0082@naver.com;
Efficacy and safety of Kumpe access catheter for pre-percutaneous nephrolithotomy renal access in modified supine percutaneous nephrolithotomy Kim, Bum Soo Kim, BS 13 교신저자 Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea ADR-9663-2022 Kim, Soo-Yeon kangjk0082@naver.com;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Heo, Jeong Heo, J 1 Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea MHQ-1390-2025 Heo, Jeong 0000-0003-0961-7851 Heo, Jeong AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Heo, Jeong Heo, J 1 Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea MHQ-1390-2025 Heo, Jeong 0000-0003-0961-7851 Heo, Jeong AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Kim, Yoon Jun Kim, YJ 2 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea J-2746-2012 Kim, Yoon AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Kim, Yoon Jun Kim, YJ 2 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea J-2746-2012 Kim, Yoon AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Lee, Sung Wook Lee, SW 3 Dong A Univ, Dong A Univ Hosp, Coll Med, Dept Internal Med, Busan, South Korea AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Lee, Youn-Jae Lee, YJ 4 Inje Univ, Busan Paik Hosp, Coll Med, Dept Internal Med, Busan, South Korea HGE-5712-2022 Lee, Yoon Jae AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Yoon, Ki Tae Yoon, KT 5 Pusan Natl Univ, Sch Med, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Byun, Kwan Soo Byun, KS 6 Korea Univ, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Jung, Yong Jin Jung, YJ 7 Seoul Natl Univ, Coll Med, Boramae Med Ctr, Div Gastroenterol,Dept Internal Med, Seoul, South Korea AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Tak, Won Young Tak, WY 8 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Jeong, Sook-Hyang Jeong, SH 9 Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Seongnam, South Korea J-5642-2012 Jeong, Sook-Hyang AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Kwon, Kyung Min Kwon, KM 10 Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA AHNSH@yuhs.ac;limys@amc.seoul.kr;
Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study Suri, Vithika Suri, V 11 Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA AHNSH@yuhs.ac;limys@amc.seoul.kr;
페이지 이동: